1. Molecular mechanisms of methylsulfonylmethane and allicin in the inhibition of CD44 ± breast cancer cells growth
    Elham Sarkhani et al, 2017, Journal of Functional Foods CrossRef
  2. Age-associated prognostic and predictive biomarkers in patients with breast cancer
    Markéta Kolečková et al, 2017 CrossRef
  3. Effect of surgical wound fluids after intraoperative electron radiotherapy on the cancer stem cell phenotype in a panel of human breast cancer cell lines
    Karolina Zaleska et al, 2016 CrossRef
  4. Metformin and melatonin inhibit DMBA-induced mammary tumorigenesis in rats fed a high-fat diet
    Bianka Bojková et al, 2017, Anti-Cancer Drugs CrossRef
  5. Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
    Huimin Wang et al, 2015, IJMS CrossRef
  6. The Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular Mechanisms.
    Ahmed Abdal Dayem et al, 2016, Nutrients CrossRef
  7. The Biological Activities of Sesterterpenoid-Type Ophiobolins
    , 2017, Marine Drugs CrossRef
  8. Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI
    Janice S. Sung et al, 2018, Breast Cancer Res Treat CrossRef
  9. Self-renewal signaling pathways in breast cancer stem cells
    Lakshmi vineela Nalla et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
  10. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast
    Nilgün Kapucuoğlu et al, 2015, Pathology - Research and Practice CrossRef
  11. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications
    Hsing-Ju Wu et al, 2019, IJMS CrossRef
  12. Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?
    Maurizio Romano et al, 2016, J. Cell. Physiol CrossRef
  13. Role of a polyphenol-enriched preparation on chemoprevention of mammary carcinoma through cancer stem cells and inflammatory pathways modulation
    Tri Vuong et al, 2016, J Transl Med CrossRef
  14. Potential biomarker panels in overall breast cancer management: advancements by multilevel diagnostics
    Shantanu Girotra et al, 2016, Personalized Medicine CrossRef
  15. CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer
    Xinyu Deng et al, 2017, Oncotarget CrossRef
  16. Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer
    Rebecca Lamb et al, 2014, Oncotarget CrossRef
  17. Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatment
    Rebecca Ward et al, 2015, Oncotarget CrossRef
  18. Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma
    Maurizio Romano et al, 2015, Oncoscience CrossRef
  19. EXPRESSION OF CD44 AND CD24 MARKERS IN BIOPSY SAMPLES OF TRIPLE NEGATIVE BREAST CANCER PATIENTS BEFORE TREATMENT
    S. G. Smirnova et al, 2020, Sib. onkol. ž. CrossRef
  20. Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer
    Mamta Kumari et al, 2020, CCDT CrossRef
  21. Breast Cancer Stem Cells: Biomarkers, Identification and Isolation Methods, Regulating Mechanisms, Cellular Origin, and Beyond
    Xiaoli Zhang et al, 2020, Cancers CrossRef
  22. Particle Therapy for Breast Cancer: Benefits and Challenges
    Wanrong Luo et al, 2021, Front. Oncol. CrossRef
  23. Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
    Zhengquan Han et al, 2015, World J Surg Onc CrossRef
  24. Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer
    Lisbeth Escudero Mendez et al, 2022 CrossRef
  25. Effects of DNA-binding ligands from dimeric bisbenzimidazoles series DBA(n) and DBPA( n) in combination with γ-radiation on epithelial-mesenchymal transition and pool size of MCF-7 breast cancer stem cells
    K. A Churiukina et al, 2023, Biofizika CrossRef
  26. Expression of cancer stem cell markers (CD24, CD44 & ALDH1A3 isoform) in Breast Cancer in Indian population considering clinicopathological characteristics and response to neoadjuvant chemotherapy – a prospective analysis from a university hospital
    Nizamuddin Ansari et al, 2024, Indian J Surg Oncol CrossRef
  27. From mitochondria to tumor suppression: ACAT1's crucial role in gastric cancer
    Wei He et al, 2024, Front. Immunol. CrossRef
  28. Encapsulated mitochondria to reprogram the metabolism of M2-type macrophages for anti-tumor therapy
    Yonghui Wang et al, 2024, Nanoscale CrossRef